Intensive treatment for patients with Crohn’s disease showed no safety differences compared to the current standard of care, according to a trial published in the journal Gastroenterology.
The findings offer some additional flexibility for treating patients with Crohn’s disease, according to Stephen Hanauer, MD, the Clifford Joseph Barborka Professor of Medicine in the Division of Gastroenterology and Hepatology and a co-author of the study.